ReviewBioengineering (Basel, Switzerland)2025
Advancement in Anaerobic Ammonia Oxidation Technologies for Industrial Wastewater Treatment and Resource Recovery: A Comprehensive Review and Perspectives.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Data-Driven Semi-Quantitative Framework for Comparative Screening and Tiering of Cellulose Nanocrystal Isolation Pathways: Implications for Process Assessment and Future Optimization.Molecules (Basel, Switzerland) · 2026Review
- Adaptation mechanisms of ANAMMOX bacteria to extreme environments.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaerobic ammonium oxidation (anammox) technologies have attracted substantial interest due to their advantages over traditional biological nitrogen removal processes, including high efficiency and low energy demand. Currently, multiple side-stream applications of the anammox coupling process have been developed, including one-stage, two-stage, and three-stage systems such as completely autotrophic nitrogen removal over nitrite, denitrifying ammonium oxidation, simultaneous nitrogen and phosphorus removal, partial denitrification-anammox, and partial nitrification and integrated fermentation denitritation. The one-stage system includes completely autotrophic nitrogen removal over nitrite, oxygen-limited autotrophic nitrification/denitrification, aerobic de-ammonification, single-stage nitrogen removal using anammox, and partial nitritation. Two-stage systems, such as the single reactor system for high-activity ammonium removal over nitrite, integrated fixed-film activated sludge, and simultaneous nitrogen and phosphorus removal, have also been developed. Three-stage systems comprise partial nitrification anammox, partial denitrification anammox, simultaneous ammonium oxidation denitrification, and partial nitrification and integrated fermentation denitritation. The performance of these systems is highly dependent on interactions between functional microbial communities, physiochemical parameters, and environmental factors. Mainstream applications are not well developed and require further research and development. Mainstream applications demand a high carbon/nitrogen ratio to maintain levels of nitrite-oxidizing bacteria, high concentrations of ammonium and nitrite in wastewater, and retention of anammox bacteria biomass. To summarize various aspects of the anammox processes, this review provides information regarding the microbial diversity of different genera of anammox bacteria and the engineering aspects of various side streams and mainstream anammox processes for wastewater treatment. Additionally, this review offers detailed insights into the challenges related to anammox technology and delivers solutions for future sustainable research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.